aluates Reports

$ 0.0

Automative

Global Oral Live Attenuated Rotavirus Vaccine Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-38X17377

BUY CHAPTERS

Global Oral Live Attenuated Rotavirus Vaccine Market Research Report 2024

Code: QYRE-Auto-38X17377

Report

July 2024

Pages:70

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck Sharp & Dohme

GSK

Bharat Biotech

Lanzhou Biological Products Research Institute

Oral Live Attenuated Rotavirus Vaccine Market

Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. Live attenuated rotavirus vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable. Oral rotavirus live attenuated vaccine refers to an oral vaccine containing attenuated rotavirus pathogens with weakened pathogenicity.

The global Oral Live Attenuated Rotavirus Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Oral Live Attenuated Rotavirus Vaccine include Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Live Attenuated Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Live Attenuated Rotavirus Vaccine.

The Oral Live Attenuated Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oral Live Attenuated Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Live Attenuated Rotavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Live Attenuated Rotavirus Vaccine Market Report

Report Metric	Details
Report Name	Oral Live Attenuated Rotavirus Vaccine Market
Segment by Type	Monovalent Vaccines Combination Vaccines
Segment by Application	Hospitals and Clinics Vaccination Sites
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Live Attenuated Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Live Attenuated Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Live Attenuated Rotavirus Vaccine Market report?

Ans: The main players in the Oral Live Attenuated Rotavirus Vaccine Market are Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute

What are the Application segmentation covered in the Oral Live Attenuated Rotavirus Vaccine Market report?

Ans: The Applications covered in the Oral Live Attenuated Rotavirus Vaccine Market report are Hospitals and Clinics, Vaccination Sites

What are the Type segmentation covered in the Oral Live Attenuated Rotavirus Vaccine Market report?

Ans: The Types covered in the Oral Live Attenuated Rotavirus Vaccine Market report are Monovalent Vaccines, Combination Vaccines

Recommended Reports

Live Attenuated Vaccines

Oral Vaccines Market

Rotavirus & Related

1 Oral Live Attenuated Rotavirus Vaccine Market Overview

1.1 Product Definition

1.2 Oral Live Attenuated Rotavirus Vaccine by Type

1.2.1 Global Oral Live Attenuated Rotavirus Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Monovalent Vaccines

1.2.3 Combination Vaccines

1.3 Oral Live Attenuated Rotavirus Vaccine by Application

1.3.1 Global Oral Live Attenuated Rotavirus Vaccine Market Value by Application (2024-2030)

1.3.2 Hospitals and Clinics

1.3.3 Vaccination Sites

1.4 Global Oral Live Attenuated Rotavirus Vaccine Market Size Estimates and Forecasts

1.4.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue 2019-2030

1.4.2 Global Oral Live Attenuated Rotavirus Vaccine Sales 2019-2030

1.4.3 Global Oral Live Attenuated Rotavirus Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Oral Live Attenuated Rotavirus Vaccine Market Competition by Manufacturers

2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Oral Live Attenuated Rotavirus Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Oral Live Attenuated Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Date of Enter into This Industry

2.8 Global Oral Live Attenuated Rotavirus Vaccine Market Competitive Situation and Trends

2.8.1 Global Oral Live Attenuated Rotavirus Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Oral Live Attenuated Rotavirus Vaccine Players Market Share by Revenue

2.8.3 Global Oral Live Attenuated Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oral Live Attenuated Rotavirus Vaccine Market Scenario by Region

3.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2019-2030

3.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2019-2024

3.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2025-2030

3.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2019-2030

3.3.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2019-2024

3.3.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2025-2030

3.4 North America Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country

3.4.1 North America Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2030)

3.4.3 North America Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country

3.5.1 Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2030)

3.5.3 Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Region (2019-2030)

3.6.3 Asia Pacific Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country

3.7.1 Latin America Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Oral Live Attenuated Rotavirus Vaccine Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2030)

4.1.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)

4.1.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2025-2030)

4.1.3 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2019-2030)

4.2.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2019-2024)

4.2.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2025-2030)

4.2.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Oral Live Attenuated Rotavirus Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2030)

5.1.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)

5.1.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2025-2030)

5.1.3 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2019-2030)

5.2.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2019-2024)

5.2.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2025-2030)

5.2.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Oral Live Attenuated Rotavirus Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck Sharp & Dohme

6.1.1 Merck Sharp & Dohme Company Information

6.1.2 Merck Sharp & Dohme Description and Business Overview

6.1.3 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolio

6.1.5 Merck Sharp & Dohme Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Bharat Biotech

6.3.1 Bharat Biotech Company Information

6.3.2 Bharat Biotech Description and Business Overview

6.3.3 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolio

6.3.5 Bharat Biotech Recent Developments/Updates

6.4 Lanzhou Biological Products Research Institute

6.4.1 Lanzhou Biological Products Research Institute Company Information

6.4.2 Lanzhou Biological Products Research Institute Description and Business Overview

6.4.3 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolio

6.4.5 Lanzhou Biological Products Research Institute Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oral Live Attenuated Rotavirus Vaccine Industry Chain Analysis

7.2 Oral Live Attenuated Rotavirus Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Live Attenuated Rotavirus Vaccine Production Mode & Process

7.4 Oral Live Attenuated Rotavirus Vaccine Sales and Marketing

7.4.1 Oral Live Attenuated Rotavirus Vaccine Sales Channels

7.4.2 Oral Live Attenuated Rotavirus Vaccine Distributors

7.5 Oral Live Attenuated Rotavirus Vaccine Customers

8 Oral Live Attenuated Rotavirus Vaccine Market Dynamics

8.1 Oral Live Attenuated Rotavirus Vaccine Industry Trends

8.2 Oral Live Attenuated Rotavirus Vaccine Market Drivers

8.3 Oral Live Attenuated Rotavirus Vaccine Market Challenges

8.4 Oral Live Attenuated Rotavirus Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck Sharp & Dohme

GSK

Bharat Biotech

Lanzhou Biological Products Research Institute

List of Tables

Table 1. Global Oral Live Attenuated Rotavirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Oral Live Attenuated Rotavirus Vaccine Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Oral Live Attenuated Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Oral Live Attenuated Rotavirus Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)

Table 5. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Oral Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Oral Live Attenuated Rotavirus Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Oral Live Attenuated Rotavirus Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Oral Live Attenuated Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Oral Live Attenuated Rotavirus Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oral Live Attenuated Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Live Attenuated Rotavirus Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Live Attenuated Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2019-2024) & (K Dose)

Table 18. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2025-2030) & (K Dose)

Table 20. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Oral Live Attenuated Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)

Table 27. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2025-2030) & (K Dose)

Table 28. North America Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)

Table 32. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2025-2030) & (K Dose)

Table 33. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Region (2019-2024) & (K Dose)

Table 37. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales by Region (2025-2030) & (K Dose)

Table 38. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Oral Live Attenuated Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)

Table 42. Latin America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2025-2030) & (K Dose)

Table 43. Latin America Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)

Table 47. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales by Country (2025-2030) & (K Dose)

Table 48. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Oral Live Attenuated Rotavirus Vaccine Sales (K Dose) by Type (2019-2024)

Table 51. Global Oral Live Attenuated Rotavirus Vaccine Sales (K Dose) by Type (2025-2030)

Table 52. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Oral Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Oral Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Oral Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2019-2024)

Table 59. Global Oral Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2025-2030)

Table 60. Global Oral Live Attenuated Rotavirus Vaccine Sales (K Dose) by Application (2019-2024)

Table 61. Global Oral Live Attenuated Rotavirus Vaccine Sales (K Dose) by Application (2025-2030)

Table 62. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Oral Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Oral Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Oral Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2019-2024)

Table 69. Global Oral Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2025-2030)

Table 70. Merck Sharp & Dohme Company Information

Table 71. Merck Sharp & Dohme Description and Business Overview

Table 72. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 73. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product

Table 74. Merck Sharp & Dohme Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 78. GSK Oral Live Attenuated Rotavirus Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Bharat Biotech Company Information

Table 81. Bharat Biotech Description and Business Overview

Table 82. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 83. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product

Table 84. Bharat Biotech Recent Developments/Updates

Table 85. Lanzhou Biological Products Research Institute Company Information

Table 86. Lanzhou Biological Products Research Institute Description and Business Overview

Table 87. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 88. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product

Table 89. Lanzhou Biological Products Research Institute Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Oral Live Attenuated Rotavirus Vaccine Distributors List

Table 93. Oral Live Attenuated Rotavirus Vaccine Customers List

Table 94. Oral Live Attenuated Rotavirus Vaccine Market Trends

Table 95. Oral Live Attenuated Rotavirus Vaccine Market Drivers

Table 96. Oral Live Attenuated Rotavirus Vaccine Market Challenges

Table 97. Oral Live Attenuated Rotavirus Vaccine Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oral Live Attenuated Rotavirus Vaccine

Figure 2. Global Oral Live Attenuated Rotavirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Oral Live Attenuated Rotavirus Vaccine Market Share by Type: 2023 & 2030

Figure 4. Monovalent Vaccines Product Picture

Figure 5. Combination Vaccines Product Picture

Figure 6. Global Oral Live Attenuated Rotavirus Vaccine Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Oral Live Attenuated Rotavirus Vaccine Market Share by Application: 2023 & 2030

Figure 8. Hospitals and Clinics

Figure 9. Vaccination Sites

Figure 10. Global Oral Live Attenuated Rotavirus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Oral Live Attenuated Rotavirus Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global Oral Live Attenuated Rotavirus Vaccine Sales (2019-2030) & (K Dose)

Figure 13. Global Oral Live Attenuated Rotavirus Vaccine Average Price (US$/Dose) & (2019-2030)

Figure 14. Oral Live Attenuated Rotavirus Vaccine Report Years Considered

Figure 15. Oral Live Attenuated Rotavirus Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global Oral Live Attenuated Rotavirus Vaccine Revenue Share by Manufacturers in 2023

Figure 17. Global 5 and 10 Largest Oral Live Attenuated Rotavirus Vaccine Players: Market Share by Revenue in Oral Live Attenuated Rotavirus Vaccine in 2023

Figure 18. Oral Live Attenuated Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. Global Oral Live Attenuated Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. United States Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2030)

Figure 41. Mexico Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Brazil Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Argentina Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Colombia Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2030)

Figure 46. Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Oral Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Oral Live Attenuated Rotavirus Vaccine by Type (2019-2030)

Figure 51. Global Revenue Market Share of Oral Live Attenuated Rotavirus Vaccine by Type (2019-2030)

Figure 52. Global Oral Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2019-2030)

Figure 53. Global Sales Market Share of Oral Live Attenuated Rotavirus Vaccine by Application (2019-2030)

Figure 54. Global Revenue Market Share of Oral Live Attenuated Rotavirus Vaccine by Application (2019-2030)

Figure 55. Global Oral Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2019-2030)

Figure 56. Oral Live Attenuated Rotavirus Vaccine Value Chain

Figure 57. Oral Live Attenuated Rotavirus Vaccine Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Multivalent Oral Rotavirus Vaccine Market Research Report 2024

Global Rotavirus Vaccine Market Research Report 2024

Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Live Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cholera Vaccines Oral Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Live Attenuated Vaccine for Pig Market Research Report 2024

Global Rotavirus Vaccines Market Insights Forecast to 2030

Bovine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poultry Live Attenuated Vaccine Market Research Report 2024

Global Human Oral Vaccine Market Research Report 2024

Global Rotavirus Infection Therapeutics Market Research Report 2024

Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Transmissble Gastroenteritis Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live Attenuated Japanese Encephalitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Live Attenuated Vaccines for Pets Market Research Report 2025

Global Live Attenuated Polio Vaccine Market Research Report 2024

Global Nasal Spray Live Attenuated Vaccine Market Research Report 2024

Global Varicella Attenuated Live Vaccine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions